RxDoctor Payments DataLook up a doctor →

David Heusinkveld, MD

Internal Medicine · Nashville, TNNPI 1962499582

Payments from drug & device makers

$23,696in general payments, 2019–2025

Across 1,398 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$4K
  • Pfizer$2K
  • Lilly USA, LLC$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • AbbVie$1K
  • Amgen$1K
  • plus $12K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk226$4,447
Pfizer117$1,718
Lilly USA, LLC103$1,578
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC75$1,461
AbbVie(2 entities)98$1,427
Amgen(2 entities)85$1,421
Kowa Pharmaceuticals America, Inc.71$946
GSK61$849
Novartis55$763
AstraZeneca42$739
Boehringer Ingelheim39$699
Otsuka America Pharmaceutical, Inc.33$679
Merck52$656
Bayer23$512
Johnson & Johnson29$485
Lundbeck LLC15$361
Sanofi-aventis U.S. LLC20$333
Amarin Pharma, Inc.22$329
Esperion Therapeutics, Inc.18$327
Takeda Pharmaceuticals U.S.A., Inc.20$301
Astellas Pharma US Inc16$294
Sumitomo Pharma America, Inc.16$281
Exact Sciences15$258
Biohaven Pharmaceuticals, Inc.12$233
Corcept Therapeutics10$233
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)8$196
Axsome Therapeutics, Inc.7$180
Sunovion Pharmaceuticals Inc.9$143
Shield Therapeutics Inc6$116
Ironwood Pharmaceuticals, Inc7$103
Avanir Pharmaceuticals, Inc.5$102
Phathom Pharmaceuticals, Inc.5$100
Eisai Inc.6$98
Abbott5$93
Regeneron Healthcare Solutions, Inc.5$86
Xeris Pharmaceuticals, Inc.4$80
Biohaven Pharmaceutical Holding Company Ltd.5$77
Collegium Pharmaceutical, Inc.4$75
Alkermes, Inc.3$69
Biogen4$69
Neurocrine Biosciences, Inc.2$68
Nestle Healthcare Nutrition Inc.3$64
Dexcom, Inc.3$58
Azurity Pharmaceuticals, Inc.3$51
Vanda Pharmaceuticals Inc.3$50
Zealand Pharma US, Inc.2$49
Idorsia Pharmaceuticals US Inc3$45
Boston Scientific3$36
Teva Pharmaceuticals USA, Inc.2$31
Nevro Corp.1$31
Jazz Pharmaceuticals Inc.1$28
Medicure Pharma Inc.1$26
Mayne Pharma Commercial LLC1$24
Daiichi Sankyo Inc.1$23
Inspire Medical Systems, Inc.1$21
Bausch & Lomb Americas Inc.1$19
Impel Pharmaceuticals Inc.1$18
Phadia US Inc.1$18
Biodelivery Sciences International, Inc.1$16
Arbor Pharmaceuticals, Inc.1$15

How this compares

$23,696 in reported general payments places this provider in the 95th percentile of 2,216 internal medicine providers in Tennessee.

See all internal medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$281,481
Medicare patients
439
Services billed
3,581

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →